RT @ASBMR: Results from a new #JBMRPlus study support the use of abaloparatide as the initial treatment in sequential therapy with alendronate in women with PMO at very high fracture risk #openaccess #freetoread @GalgoMedical @UMichDentistry https://t.co/BR93zYDDOT https://t.co/XB4Chhqgri


from Twitter https://twitter.com/GastonR48222321

February 22, 2022 at 05:26PM

Comentarios

Entradas más populares de este blog

RT @The_JBMR: Authors from @TwinsUKres suggest that Proton pump inhibitors use may influence total hip BMD, both directly and indirectly, via plasma metabolites involved in the sex hormone pathway @YasrabRaza @ruthcbowyer @kerrin_small @DrClaireSteves @MarioFalchi https://t.co/hHvSzCIv7y https://t.co/bHA8gNuGzZ

RT @iofbonehealth: IOF and ESCEO have announced that WCO-IOF-ESCEO 2022 has been transitioned to a fully virtual format, held from March 24-26, 2022. Including many ‘live’ virtual sessions with Q&A, the program will be available on-demand for 3 months post-congress. https://t.co/nBsqR4z9wz https://t.co/giROkJxixr